Unsupported browser

For a better experience please update your browser to its latest version.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more


  • Comment

Work has started on Sheppard Robson's £8.2 million centre for research into the causes and treatment of diabetes. The 5,300m 2building is being constructed for the Oxford Radcliffe Hospitals NHS Trust, pharmaceutical company Novo Nordisk and the University of Oxford. It is to consist of a pair of two-storey clinical facilities flanking a triangular atrium.The third side will be enclosed by a three-storey research building. The complex incorporates an energy-saving aerofoil roof.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions.

Links may be included in your comments but HTML is not permitted.